Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesFrom somatostatin to octreotide LAR: evolution of a somatostatin analogue
Current Medical Research and Opinion, 11/05/09
Anthony L et al. – Octreotide is a potent synthetic somatostatin analogue that has become the mainstay of medical therapy for tumor control in neuroendocrine disorders such as acromegaly and GEP–NETs. The development of octreotide LAR offered a further advancement; less frequent dosing provided valuable benefits in quality of life to patients, with equivalent efficacy and tolerability. Moreover, recent results from the PROMID study have confirmed the antiproliferative effect of octreotide LAR in patients with well–differentiated metastatic GEP–NETs of the midgut. New therapeutic uses of octreotide are currently under investigation in a variety of clinical settings.
Related Articles
Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.
BMC Cancer, 11/09/09
Relevance Score: 87%
High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
Anticancer Research, 11/11/09
Relevance Score: 85%
Treatment of Malignant Enterovesical Fistula with Octreotide
Journal of Palliative Medicine, 10/12/09
Relevance Score: 85%
The Efficacy of Octreotide LAR as Firstline Therapy for Patients with Newly Diagnosed Acromegaly is Independent of Tumor Extension: Predictive Factors of Tumor and Biochemical Response
Hormone and Metabolic Research, 10/06/09
Relevance Score: 85%
Resolution of chyloperitoneum in a preterm with octreotide, diet and cessation of dialysis
Pediatric Nephrology, 11/16/09
Relevance Score: 84%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
International Journal of Women's Health, 12/18/09
Zigzagged Augmentation Index in Diabetes
Clinical and Experimental Hypertension, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor